1. Home
  2. PRPO vs SILO Comparison

PRPO vs SILO Comparison

Compare PRPO & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • SILO
  • Stock Information
  • Founded
  • PRPO N/A
  • SILO 2010
  • Country
  • PRPO United States
  • SILO United States
  • Employees
  • PRPO N/A
  • SILO N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • SILO Apparel
  • Sector
  • PRPO Industrials
  • SILO Consumer Discretionary
  • Exchange
  • PRPO Nasdaq
  • SILO Nasdaq
  • Market Cap
  • PRPO 9.9M
  • SILO 8.8M
  • IPO Year
  • PRPO N/A
  • SILO N/A
  • Fundamental
  • Price
  • PRPO $6.65
  • SILO $1.65
  • Analyst Decision
  • PRPO
  • SILO
  • Analyst Count
  • PRPO 0
  • SILO 0
  • Target Price
  • PRPO N/A
  • SILO N/A
  • AVG Volume (30 Days)
  • PRPO 6.8K
  • SILO 805.4K
  • Earning Date
  • PRPO 03-28-2025
  • SILO 02-18-2025
  • Dividend Yield
  • PRPO N/A
  • SILO N/A
  • EPS Growth
  • PRPO N/A
  • SILO N/A
  • EPS
  • PRPO N/A
  • SILO N/A
  • Revenue
  • PRPO $17,411,000.00
  • SILO $72,102.00
  • Revenue This Year
  • PRPO $75.18
  • SILO $1.86
  • Revenue Next Year
  • PRPO N/A
  • SILO N/A
  • P/E Ratio
  • PRPO N/A
  • SILO N/A
  • Revenue Growth
  • PRPO 31.31
  • SILO N/A
  • 52 Week Low
  • PRPO $4.31
  • SILO $0.77
  • 52 Week High
  • PRPO $7.20
  • SILO $4.50
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 63.80
  • SILO 52.57
  • Support Level
  • PRPO $6.52
  • SILO $1.56
  • Resistance Level
  • PRPO $6.90
  • SILO $1.89
  • Average True Range (ATR)
  • PRPO 0.27
  • SILO 0.19
  • MACD
  • PRPO 0.03
  • SILO -0.05
  • Stochastic Oscillator
  • PRPO 89.90
  • SILO 27.12

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: